iiinova — where your digital self keeps evolving

BioMed X @biomedx.bsky.social · 23/06/2026

🚀 Applications are now open for our new global #Neuroimmunology research call, supported by Biogen. 📅 Deadline: August 16, 2026 🔗 Learn more & apply: career.bmedx.com/call/2026-NH... #Neuroimmunology #Neuroscience #Immunology #ResearchOpportunity #BioMedX

000

BioMed X @biomedx.bsky.social · 25/02/2026

📌 12 days left 📌 𝐂𝐚𝐥𝐥 𝐟𝐨𝐫 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧: 𝐀𝐝𝐯𝐚𝐧𝐜𝐢𝐧𝐠 𝐏𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐟𝐨𝐫 𝐄𝐚𝐫𝐥𝐲 𝐃𝐢𝐚𝐛𝐞𝐭𝐢𝐜 𝐊𝐢𝐝𝐧𝐞𝐲 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 This research project is supported by the Government of Barbados and the European Union. We are looking for your application. For more information, please visit career.bmedx.com/call/2026-BR...

000

BioMed X @biomedx.bsky.social · 04/12/2025

𝐉𝐨𝐢𝐧 𝐨𝐮𝐫 𝐮𝐩𝐜𝐨𝐦𝐢𝐧𝐠 #InfoSession! 🧬 An online #webinar to learn more about our open Call for Application for a new collaborative research project with AbbVie about: “𝐂𝐢𝐫𝐜𝐮𝐢𝐭-𝐁𝐚𝐬𝐞𝐝 𝐌𝐨𝐝𝐞𝐥 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐨𝐟 𝐀𝐧𝐡𝐞𝐝𝐨𝐧𝐢𝐚.” Save the date for the exciting #discussion and career #opportunities in neuroscience!

010

BioMed X @biomedx.bsky.social · 25/11/2025

📢 Call for Application 📢 Join BioMed X and AbbVie in Advancing Neuroscience Research We invite you to join our next collaborative research project: “𝐂𝐢𝐫𝐜𝐮𝐢𝐭-𝐁𝐚𝐬𝐞𝐝 𝐌𝐨𝐝𝐞𝐥 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐨𝐟 𝐀𝐧𝐡𝐞𝐝𝐨𝐧𝐢𝐚.” Discover more about the research project in our Career Space: career.bmedx.com/call/2025-NH...

010

BioMed X @biomedx.bsky.social · 05/11/2025

📢 𝐉𝐨𝐢𝐧 𝐨𝐮𝐫 𝐮𝐩𝐜𝐨𝐦𝐢𝐧𝐠 #InfoSession! BioMed X Institute invites you to a webinar to learn more about the open Call for Applications for the first XFem Labs research project: “𝐍𝐞𝐰 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐟𝐨𝐫 𝐅𝐞𝐦𝐚𝐥𝐞-𝐂𝐨𝐧𝐭𝐫𝐨𝐥𝐥𝐞𝐝 𝐍𝐨𝐧-𝐇𝐨𝐫𝐦𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐭𝐫𝐚𝐜𝐞𝐩𝐭𝐢𝐨𝐧.” Register now: us02web.zoom.us/webinar/regi...

010

BioMed X @biomedx.bsky.social · 15/10/2025

🚨 𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗡𝗲𝘄𝘀: 𝗕𝗶𝗼𝗠𝗲𝗱 𝗫 𝗹𝗮𝘂𝗻𝗰𝗵𝗲𝘀 𝗪𝗼𝗺𝗲𝗻’𝘀 𝗛𝗲𝗮𝗹𝘁𝗵 𝗥&𝗗 𝗔𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗼𝗿 𝗶𝗻 𝗛𝗲𝗶𝗱𝗲𝗹𝗯𝗲𝗿𝗴 The first initiative supported by the Gates Foundation. Discover our first research project here: bmedx.com/news-events/... Don't miss the chance to shape the #future of women’s health! We're excited about your ideas💡

010

BioMed X @biomedx.bsky.social · 14/10/2025

New Call for Applications! Shaping the future of #women’s #health 🚀 #BioMedX & #GatesFoundation join forces to tackle one of the most pressing challenges in biomedical research: female-controlled, non-hormonal contraception. Submit your proposal via our CareerSpace: career.bmedx.com/call/2025-XF...

011

BioMed X @biomedx.bsky.social · 29/09/2025

🚨 New episode of #VoicesOfBioMedX! 🎙️ Meet Elizaveta, a Research Assistant from team #TMI at BioMed X, as she shares her motivation to work in an innovative environment where academic research closely connects with translational projects. Listen to the interview: www.youtube.com/watch?v=ARPz...

youtube.com

Day in the life of a Research Assistant | Elizaveta Savochkina | Voices of BiomedX EP 06

YouTube video by BioMed X Institute

020

BioMed X @biomedx.bsky.social · 24/09/2025

Join us at @events.embl.org Heidelberg for an inspiring #webinar with Christian Tidona, Founder and Managing Director of BioMed X Institute 🎙 📅 Visit us at EMBL Heidelberg or join 🌐Online via Zoom 🕚 October 10th, 2025 | 11:00 – 12:00 (CEST) 👉 Register here: embl-org.zoom.us/webinar/regi...

010

BioMed X @biomedx.bsky.social · 19/08/2025

New Call for Application! Reimagining drug delivery 🚀 #BioMedX + #NovoNordisk join forces to tackle one of the toughest challenges in biomedicine: #oral #peptide #formulations. ➡️ Register and apply via our BioMed X Career Space: lnkd.in/e4i3S3Yw 📅 Submit your proposal before #October 12, 2025

010

BioMed X @biomedx.bsky.social · 12/08/2025

🚨 New episode of #VoicesOfBioMedX! 🎙️ Meet Dr. Semih Akincilar, Group Leader at BioMed X, as he explains how targeting DNA damage response (DDR) pathways could transform cancer immunotherapy. 🔬 Learn more about his innovative research to make immune-resistant tumors responsive!

020

BioMed X @biomedx.bsky.social · 09/07/2025

💡 New Call for Application: BioMed X & #Servier are launching the first XSeed Labs research project in Paris-Saclay! Focus: #AI-powered design of #bispecific #antibodies for #cancer #therapy. 🧬 Submit your proposal by August 31 2025: career.bmedx.com/call/2025-XP...

010

Reposted by BioMed X

Institute of Molecular Biology (IMB) @imbmainz.bsky.social · 27/06/2025

A day well spent at the 2nd Life Sciences Postdoc Symposium. Thank you to our speakers Christian Tidona @biomedx.bsky.social, Eckhard Thines @unimainz.bsky.social, Marie-Theres Weil #BioNTech & Verawan Boonsanay-Michel #sanofi for their inspiring contributions. And of course to all our participants!

032

BioMed X @biomedx.bsky.social · 12/06/2025

Info Session on “New Platform for Next-Generation Intraocular Biologics" in partnership with #Boehringer #Ingelheim Call! Available positions for this call include: 1 Group Leader, 2 Postdoctoral Researchers, and 2 Research Assistants us02web.zoom.us/webinar/regi...

010

BioMed X @biomedx.bsky.social · 05/06/2025

Are you a U.S.-based academic PI who lost (or may lose) #NIHfunding? 🧠 Apply for #XBridge by @BioMed_X — a new way to continue your research in a fully funded pharma–academia setting in 🇩🇪 Heidelberg or 🇺🇸 New Haven. 🎥 Missed the webinar? Catch the replay now! youtu.be/miqF_wnclOg #biomedicalresearch

000

Reposted by BioMed X

Centro Nacional de Biotecnología (CNB) @cnb-csic.bsky.social · 29/05/2025

📢 Don't miss tomorrow's seminar: 'Tracing mitochondrial Dysfunction Signatures in Aging and Autoimmunity', by Dr Gorjana Rackov from the BioMed X Institute, Heidelberg (@biomedx.bsky.social), Germany. 🗓️ 30 May 🕛 12:00 📍 CNB Lecture Hall #CNB_CSIC

011

BioMed X @biomedx.bsky.social · 22/05/2025

@BioMedXInst & @Boehringer invite researchers to develop next-gen intraocular biologics at #XSeedLabs (CT, USA) to reduce the burden of frequent injections in #retinal disease. Apply by July 12 👉 career.bmedx.com/call/2025-RD... #biologics #ophthalmology #pharma

career.bmedx.com

BioMed X Institute

BioMed X Application System

000

BioMed X @biomedx.bsky.social · 12/05/2025

We’re launching our first collaboration with Daiichi Sankyo Co., Ltd. on "New Strategies for Targeting Solid Tumors with Multi-Specific Biologics". Boot camp kicks off in Heidelberg—welcome to our partners & participants! 🔗 bmedx.com/news-events/...

000

BioMed X @biomedx.bsky.social · 08/05/2025

🎉Congratulations to our #PTA Team on receiving three 𝐄𝐅𝐈𝐒-𝐄𝐉𝐈 𝐘𝐨𝐮𝐧𝐠 𝐈𝐧𝐯𝐞𝐬𝐭𝐢𝐠𝐚𝐭𝐨𝐫 𝐓𝐫𝐚𝐯𝐞𝐥 𝐀𝐰𝐚𝐫𝐝𝐬 at the 4th #Resolution #Days Meeting in Frankfurt!

010

BioMed X @biomedx.bsky.social · 08/04/2025

🌉 Today we launch #XBridge: a unique matchmaking program for U.S. researchers hit by #NIH #funding gaps. We invite PIs to submit existing NIH proposals to connect with pharma partners via our platform. bio.mx/news/press-r... Not a grant—an opportunity to keep science moving. #StandUpForScience 🔬

053

BioMed X @biomedx.bsky.social · 31/03/2025

We are excited to announce that @johnmlindner.bsky.social , our Head of Immunology Discovery & Head of Research USA, will be introducing T-FINDER at the 6th TCR-Based Therapies Summit in Boston on Wednesday, April 2, 2025. #precision #immunotherapy. tcr-therapies-summit.com/day-one/?utm...

000

BioMed X @biomedx.bsky.social · 21/03/2025

🔬 Advancing AI in Drug Development: BioMed X Institute at #ICLR2025 integrating #ComputationalBiology, and #KnowledgeGraphs, and #AgenticAI to transform drug development and clinical translation. Congratulations Team VPE!

000

BioMed X @biomedx.bsky.social · 18/03/2025

Our Group Leader, Kyungbo Kim, at 2025 China International Biotechnology Conference in Beijing (April 16-18, 2025)!Novel approach transporting complex macromolecules, even micron-sized bacteria across the intestinal epithelium, by harnessing gut immune cells. nbc2025.eventscribe.net/index.asp?pr...

000

BioMed X @biomedx.bsky.social · 12/03/2025

🔬 The Diary of a Scientist: A Webinar Series on Careers in Science 🎙️What does it really take to build a career in science? How do you navigate the transition between academia and industry? Register for free: webinar! us02web.zoom.us/webinar/regi...

000

BioMed X @biomedx.bsky.social · 10/03/2025

Deadline extended! You have time to submit your proposal until TOMORROW March 11th!

000

BioMed X @biomedx.bsky.social · 05/03/2025

🚀 𝗡𝗘𝗪 𝗖𝗮𝗹𝗹: 𝗦𝘁𝗮𝗿𝘁 𝗬𝗼𝘂𝗿 𝗢𝘄𝗻 𝗔𝗜-𝗣𝗼𝘄𝗲𝗿𝗲𝗱 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 𝗖𝗼𝗺𝗽𝗮𝗻𝘆 𝗶𝗻 𝗜𝘀𝗿𝗮𝗲𝗹!🔹 We are looking for: 🧑‍🔬 𝟭 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝘀𝘁 𝗙𝗼𝘂𝗻𝗱𝗲𝗿 & 𝟮 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝘀𝘁 𝗖𝗼-𝗙𝗼𝘂𝗻𝗱𝗲𝗿𝘀 – Experts in computational biology, ML, bioinformatics, language models, encryption, and complex disease biology. career.bio.mx/call/2025-AI...

010

Reposted by BioMed X

Ursula von der Leyen @vonderleyen.ec.europa.eu · 19/02/2025

Signed! Two Global Gateway projects with huge potential for Barbados. One agreement with @biomedx.bsky.social for pharmaceutical innovation. And the first green hydrogen storage facility of the Caribbean with HDF Energy.

738938

BioMed X @biomedx.bsky.social · 10/02/2025

Virtual patients and biomedical knowledge graphs—two groundbreaking technologies, yet often developed in isolation. Now, it's time to change that. Join our next #Hackathon and be part of the future. docs.google.com/forms/d/e/1F...

000

BioMed X @biomedx.bsky.social · 05/02/2025

🚀 Advancing High-Dimensional Flow Cytometry at BioMed X! Advanced Spectral Flow Cytometry Workshop, mastering the design, execution, and analysis of high-dimensional flow experiments using the Sony ID7000. #FlowCytometry

000

BioMed X @biomedx.bsky.social · 04/02/2025

𝐖𝐡𝐚𝐭 𝐢𝐟 𝐮𝐧𝐥𝐨𝐜𝐤𝐢𝐧𝐠 𝐭𝐡𝐞 𝐬𝐞𝐜𝐫𝐞𝐭𝐬 𝐨𝐟 𝐧𝐞𝐮𝐭𝐫𝐨𝐩𝐡𝐢𝐥 𝐛𝐞𝐡𝐚𝐯𝐢𝐨𝐫 𝐜𝐨𝐮𝐥𝐝 𝐫𝐞𝐝𝐞𝐟𝐢𝐧𝐞 𝐜𝐚𝐧𝐜𝐞𝐫 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭? Immunity review on neutrophil plasticity in cancer and emerging strategies to reprogram them from tumor accomplices to fighters. pubmed.ncbi.nlm.nih.gov/39813993/one How we address this: bio.mx/research-tea...

pubmed.ncbi.nlm.nih.gov

Adaptations of neutrophils in cancer - PubMed

There is a renewed interest in neutrophil biology, largely instigated by their prominence in cancer. From an immunologist's perspective, a conceptual breakthrough is the realization that prototypical ...

000

BioMed X @biomedx.bsky.social · 28/01/2025

New magnetoelectric nanodiscs (MENDs), featured in Nature Nanotechnology, deliver electrical pulses to neurons via magnetic fields—no genetic modification needed. C𝗼𝘂𝗹𝗱 they 𝘁𝗮𝗿𝗴𝗲𝘁 𝘀𝗽𝗲𝗰𝗶𝗳𝗶𝗰 𝗯𝗿𝗮𝗶𝗻 𝗰𝗶𝗿𝗰𝘂𝗶𝘁𝘀 𝗱𝘆𝘀𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗲𝗱 𝗶𝗻 𝗽𝘀𝘆𝗰𝗵𝗶𝗮𝘁𝗿𝗶𝗰 𝗱𝗶𝘀𝗼𝗿𝗱𝗲𝗿𝘀? www.nature.com/articles/s41...

nature.com

Magnetoelectric nanodiscs enable wireless transgene-free neuromodulation - Nature Nanotechnology

In this study, the authors present magnetoelectric nanodiscs that enable minimally invasive, remote magnetic neuromodulation with subsecond precision to drive reward and motor behaviours in geneticall...

010

Reposted by BioMed X

Hidehito HORINOUCHI @hhorinouchi.bsky.social · 19/01/2025

🔥@nature.com🆙 ✅Targeting protein–ligand neosurfaces with a generalizable deep learning tool 🎯Geometric deep learning approach based on learned molecular surface representations 👥Dr. Anthony Marchand #LCSM @oncoalert.bsky.social www.nature.com/articles/s41...

nature.com

Targeting protein–ligand neosurfaces with a generalizable deep learning tool - Nature

A computational deep learning approach is used to design synthetic proteins that target the neosurfaces formed by protein–ligand interactions, with applications in the development of new therapeutic m...

055

BioMed X @biomedx.bsky.social · 15/01/2025

🚨 New Call for Application Alert! 🚨 💡 Project Title: New Strategies for Targeting of Solid Tumors with Multi-Specific Biologics (MTT) 🤝In collaboration with Daiichi Sankyo 🌍Location: Heidelberg 🗓️Apply by: March 9, 2025 📍Innovation Boot Camp: May 12-16, 2025 🔗Apply here: career.bio.mx/call/2025-BM...

020

BioMed X @biomedx.bsky.social · 13/01/2025

📢 Reminder! Our 𝗕𝗜𝗢𝗗𝗔𝗧𝗔𝗧𝗛𝗢𝗡 is happening in just two days!🌟 Participants will contribute to the open-source project AIAgents4Pharma: lnkd.in/eKk2cP5W – a initiative by the VPE Team in collaboration with the European Bioinformatics Institute | @ebi.embl.org, SRH University and Sanofi.

lnkd.in

This link will take you to a page that’s not on LinkedIn

010

BioMed X @biomedx.bsky.social · 02/01/2025

The #tumor microenvironments of all cancers can be classified into 12 distinct #immune #archetypes, each with unique cell compositions & gene expression profiles. 🔗Nature Reviews #Cancer (2023): lnkd.in/eADP2j_y 🔗Original Study in Cell (2022): lnkd.in/ewJWhZsk 👉Our research team: shorturl.at/e2pHd

shorturl.at

Team NST – BioMed X Institute

The objective of team NST is to study neutrophil biology in the context of solid tumors, in order to design improved immunotherapies.

010

BioMed X @biomedx.bsky.social · 16/12/2024

🧵 Breakthrough in noninvasive imaging from @mitofficial.bsky.social laser-based technique deeper into living tissue 💡Label-free imaging preserves tissue in its natural state. 💡Deeper penetration (700μm vs. 200μm previously). 💡Faster imaging speeds. #Science#Innovation news.mit.edu/2024/noninva...

news.mit.edu

Noninvasive imaging method can penetrate deeper into living tissue

MIT researchers developed a non-invasive imaging technique that enables laser light to penetrate deeper into living tissue, capturing sharper images of cells. This could help clinical biologists study...

000

BioMed X @biomedx.bsky.social · 13/12/2024

🎉 Congrats to Immunai & AION Labs for making the top 10 companies awared by R&D - Research & Development World shaping #AI in #biotech & #bio-convergence! 🚀 Both built on the BioMed X model, they're pushing R&D boundaries & shaping the future of healthcare. 🌍🧬 www.rdworldonline.com/25-techbio-l...

rdworldonline.com

Exascale computing met techbio platform consolidation in 2024

In 2024, billion-dollar techbio consolidation revealed convergence of supercomputing, ML architectures, and therapeutic validation pipelines.

010

BioMed X @biomedx.bsky.social · 02/12/2024

We’re proud to share that Olivia, a PhD student on our #TMI team, has won the Top Poster Award at the Controlled Release Society – CRS 2024 Annual Meeting! 🏆 Let's continue to push boundaries and inspire innovation in delivery science together. #Innovation #CRS2024 #pharmaresearch #deliveryscience

000

BioMed X @biomedx.bsky.social · 28/11/2024

AI-Driven Drug Development: Safer, But More Effective? 📊 AI-derived drugs: 🔬 80–90% success in phase 1 (higher than avg) 📈 ~40% in phase 2 (on par w/ avg) 🧩 Phase 3? Still a challenge Join us for our webinar! 📅 Dec 17 | 12 PM CET | 12 PM EST | 9 AM PT 📍https://bit.ly/415MYr8 #AI #PharmaRND

000

BioMed X @biomedx.bsky.social · 28/11/2024

Groundbreaking study published in #ScienceAdvances introduces #T-FINDER, the platform revolutionizing the discovery of functional T cell receptors (TCRs) and their ligands across diverse human leukocyte antigen (HLA) types.🧬 www.science.org/doi/10.1126/... #Science #Immunotherapy #PrecisionMedicine

science.org

T-FINDER: A highly sensitive, pan-HLA platform for functional T cell receptor and ligand discovery

The modular T-FINDER platform enables rapid and robust characterization of disease-relevant T cell receptors and ligands.

010

Reposted by BioMed X

John Lindner @johnmlindner.bsky.social · 18/11/2024

As part of my role as Head of Research for US-based BioMed X teams: Alicia Cutler's Team CHM (based in New Haven, CT) is #recruiting an #immunology expert (postdoctoral fellow) to study the role of #inflammation in #vasculature using unique, complex, 3-D models: career.bio.mx/call/2024-NH...

career.bio.mx

BioMed X Institute

BioMed X Application System

152